The spectrum and changes of biopsy-proven kidney diseases in Chinese children

被引:6
|
作者
He, Guohua [1 ]
Tao, Liyuan [2 ]
Li, Chenglong [3 ]
Zhong, Xuhui [1 ]
Wang, Haibo [4 ]
Ding, Jie [1 ]
机构
[1] Peking Univ First Hosp, Dept Pediat, Beijing, Peoples R China
[2] Peking Univ Third Hosp, Res Ctr Clin Epidemiol, Beijing, Peoples R China
[3] Peking Univ, Peking Univ First Hosp, Clin Res Inst, Beijing, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 1, Clin Trial Unit, Guangzhou, Peoples R China
基金
中央高校基本科研业务费专项资金资助; 北京市自然科学基金;
关键词
Children; Biopsy; Pathology; SINGLE-CENTER EXPERIENCE; RENAL BIOPSY; GLOMERULAR-DISEASES; MORTALITY;
D O I
10.1007/s40620-022-01527-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aim The study aimed to investigate the spectrum of biopsy-proven kidney disease in Chinese children. Methods Records of children 0-17 years old who underwent native kidney biopsy from June 1st, 2013 to December 31st, 2018 in the national inpatients' database of China were analyzed. Biopsy-proven kidney diseases of different sex, age groups, and diagnosis, and the changing patterns of kidney disease compared with the previous study were analyzed. Results A total of 21,311 patients from 232 hospitals with a median age of 11.34 years were included. Immunoglobulin A vasculitis with nephritis (IgAVN) was the most common pathological finding [29.17%, 95% confidence interval (confidence interval, CI) = 28.56-29.78], followed by IgA nephropathy (IgAN) (22.70%, 95% CI = 22.14-23.27). IgAN was the most common finding in patients with hematuria (60.75%, 95% CI = 58.83-62.65], proteinuria (33.43%, 95% CI = 30.54-36.42), and hematuria plus proteinuria (62.77%, 95% CI = 56.19-69.02). Minimal change disease was the most common finding (40.69%, 95% CI = 39.41-41.98) in nephrotic syndrome. The proportion of IgAVN in patients with biopsy-proven glomerular disease increased year by year during 2013-2018 (p for trend < 0.001) and was higher than that of 2004-2014 [29.41% (95% CI = 29.10-29.72) in 2013-2018 vs. 13.35% (95% CI = 12.97-13.73) 2004-2014, p < 0.001]. The proportion of hepatitis B virus associated nephritis during 2013-2018 was lower than that of 2004-2014 [0.44% (95% CI = 0.36-0.54) in 2013-2018 vs. 0.87% (95% CI = 0.67-1.10) in 2004-2014, p < 0.001]. Conclusions IgAVN and IgAN were the most common types of pathological findings in children who underwent kidney biopsies from 2013 to 2018. The pathological spectrum of kidney biopsy changed over time.
引用
收藏
页码:417 / 427
页数:11
相关论文
共 50 条
  • [41] The Natural Course of Biopsy-Proven Isolated Microscopic Hematuria: A Single Center Experience of 350 Patients
    Lee, Hae Min
    Hyun, Ji In
    Min, Ji-Won
    Lee, Kyungsoo
    Kim, Yong Kyun
    Choi, Euy Jin
    Song, Ho Cheol
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2016, 31 (06) : 909 - 914
  • [42] Biopsy-proven liver cirrhosis in young children: A 10-year cohort study
    Dong, Yi
    Li, Aiqin
    Zhu, Shishu
    Chen, Weibin
    Li, Meina
    Zhao, Pan
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (06) : 959 - 963
  • [43] Pattern of biopsy-proven kidney disease in the elderly in a tertiary care hospital in India: a clinicopathological study
    Bagchi, Soumita
    Mittal, Parmod
    Singh, Geetika
    Agarwal, Sanjay Kumar
    Singh, Lavleen
    Bhowmik, Dipankar
    Mahajan, Sandeep
    Dinda, Amit
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2016, 48 (04) : 553 - 560
  • [44] Etiologic Spectrum of Biopsy-Proven Peripheral Neuropathies in Childhood from a Resource-Poor Setting
    Krishnan, Pramod
    Mahadevan, Anita
    Bindu, Parayil Sankaran
    Chickabasaviah, Yasha T.
    Taly, Arun B.
    JOURNAL OF CHILD NEUROLOGY, 2015, 30 (06) : 707 - 715
  • [45] Epidemiologic Data of Biopsy-Proven Renal Diseases: Experience from a Single Center in South India
    Bandi, Varun Kumar
    Nalamati, Ammanna
    Kasinaboina, Bharathi
    Chundru, Sai Swapna
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2019, 30 (02) : 478 - 491
  • [46] Prevalence and Clinical Findings of Biopsy-Proven Glomerulonephritidis in Iran
    Naini, Afsoon Emami
    Harandi, Ali Amini
    Ossareh, Shahrzad
    Ghods, Ahad
    Bastani, Bahar
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2007, 18 (04) : 556 - 564
  • [47] CLINICAL CHARACTERISTICS OF BIOPSY-PROVEN RENAL SARCOIDOSIS IN JAPAN
    Kamata, Yoshinori
    Sato, Hiroshi
    Joh, Kensuke
    Tsuchiya, Yoshinori
    Kunugi, Shinobu
    Shimizu, Akira
    Konta, Tsuneo
    Baughman, Robert P.
    Azuma, Arata
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2018, 35 (03) : 252 - 260
  • [48] Biopsy-proven acute phosphate nephropathy: A case report
    Medina-Liabres, Kristianne Rachel Palanca
    Kim, Bo Mi
    Kim, Sejoong
    WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (12) : 2585 - 2589
  • [49] Clinical prognostic factors in biopsy-proven benign nephrosclerosis
    Vikse, BE
    Aasarod, K
    Bostad, L
    Iversen, BM
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (03) : 517 - 523
  • [50] Clinical characteristics and outcomes of biopsy-proven diabetic nephropathy
    Zhuo, Li
    Zhang, Nianrong
    Zou, Guming
    Chen, Dapeng
    Li, Wenge
    FRONTIERS OF MEDICINE, 2017, 11 (03) : 386 - 392